Population aging, macroeconomic changes, and global diabetes prevalence, 1990–2008

Abstract

BackgroundDiabetes is an important contributor to global morbidity and mortality. The contributions of population aging and macroeconomic changes to the growth in diabetes prevalence over the past 20 years are unclear.MethodsWe used cross-sectional data on age- and sex-specific counts of people with diabetes by country, national population estimates, and country-specific macroeconomic variables for the years 1990, 2000, and 2008. Decomposition analysis was performed to quantify the contribution of population aging to the change in global diabetes prevalence between 1990 and 2008. Next, age-standardization was used to estimate the contribution of age composition to differences in diabetes prevalence between high-income (HIC) and low-to-middle-income countries (LMICs). Finally, we used non-parametric correlation and multivariate first-difference regression estimates to examine the relationship between macroeconomic changes and the change in diabetes prevalence between 1990 and 2008.ResultsGlobally, diabetes prevalence grew by two percentage points between 1990 (7.4 %) and 2008 (9.4 %). Population aging was responsible for 19 % of the growth, with 81 % attributable to increases in the age-specific prevalences. In both LMICs and HICs, about half the growth in age-specific prevalences was from increasing levels of diabetes between ages 45–65 (51 % in HICs and 46 % in LMICs). After age-standardization, the difference in the prevalence of diabetes between LMICs and HICs was larger (1.9 % point difference in 1990; 1.5 % point difference in 2008). We found no evidence that macroeconomic changes were associated with the growth in diabetes prevalence.ConclusionsPopulation aging explains a minority of the recent growth in global diabetes prevalence. The increase in global diabetes between 1990 and 2008 was primarily due to an increase in the prevalence of diabetes at ages 45–65. We do not find evidence that basic indicators of economic growth, development, globalization, or urbanization were related to rising levels of diabetes between 1990 and 2008.Electronic supplementary materialThe online version of this article (doi:10.1186/s12963-015-0065-x) contains supplementary material, which is available to authorized users.

Factors Associated with Poor Glycemic Control among Patients with Type 2 Diabetes in the Southeast Region of Brazil

“…Diabetes has historically had a higher burden in high-income countries, but the disease is growing rapidly in low-to-middle-income countries. Data from a large study analyzing 198 countries between 2000 and 2008 indicated that overall diabetes prevalence grew by two percentage points between 1990 (7.4%) and 2008 (9.4%), with a similar level of growth for low-to-middle income countries (7.5-9.3%) [2]. Accordingly, another study involving 4372 million participants in 200 countries showed that low and middle-income countries replaced European countries on the list of the top ten countries with the highest prevalence of diabetes [3].…”

Tuberculosis and Diabetes Mellitus Comorbidity among the Ageing Population: A Threat to the Public Health System of Nepal

“…31 Ageing of the population was accountable for 19% of the progress of diabetes mellitus, rise in the age-specific prevalence of diabetes was attributed by 81%. 32 Diabetes was slightly higher among male (10.5%) than female (7.9%). The prevalence of overweight was 16.70%.…”

Standard mortality rates and years of life lost for serologically defined adult-onset type 1 and type 2 diabetes – A fifteen year follow-up

“…In patients with diabetes mortality has repeatedly been described to be increased compared to the general population [4][5][6][7]. The global burden of diabetes has increased substantially in most parts of the world over the past decades [8][9][10][11]. Mortality in persons with diabetes has been described to decrease in parallel with, but still at higher levels than, the mortality trends in the general populations [4,12,13].…”

“…Mortality in persons with diabetes has been described to decrease in parallel with, but still at higher levels than, the mortality trends in the general populations [4,12,13]. While the incidence and prevalence rates of diabetes are still increasing in most regions [8][9][10], more intensified and multimodal evidence-based treatment is believed to have contributed to the decline in mortality, besides the growth and aging of populations [4,5,9,11,14]. There is, however, a paucity of data regarding excess mortality risk in diabetes with regard to age, sex and, especially, types of diabetes [4,15].…”